Publications
5808 Results
- Journal / Conference
- Molecular Carcinogenesis Mar;57(3):462-466; Jan 10 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Cancer Control
- PMID
- PMID29318656
- PMC
- PMC5840353
- Study Number(s)
- SWOG-9217
Circadian Genes and Risk of Prostate Cancer in the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of Patient-Reported Outcomes
- Year
- 2018
- Research Committee(s)
- Genitourinary
- PMID
- PMID29951640
- PMC
- PMC5997724
- Study Number(s)
- S0421
Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)
- Journal / Conference
- Journal of Clinical Oncology, Mar 1;36(7):697-703; Jan 22 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Lymphoma
- PMID
- PMID29356608
- PMC
- PMC Journal - In Process
- Study Number(s)
- S0016
Continued excellent outcomes in previously untreated follicular lymphoma patients after treatment with CHOP plus Rituximab or CHOP plus 131Iodine-Tositumomab - long term follow-up of phase III randomized study SWOG-S0016
- Journal / Conference
- New England Journal of Medicine Mar 29;378(13):1177-1188
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID29590544
- PMC
- PMC6426127
- Study Number(s)
- CTSU/C80702
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- Journal / Conference
- JAMA Oncology Jun 1;4(6):783-790; Apr 12. doi: 10.1001/jamaoncol.2018.0126. [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID29710284
- PMC
- PMC6145685
- Study Number(s)
- C89803
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial
- Journal / Conference
- Journal of Clinical Oncology 36(suppl 4S; abstr 208); ASCO Gastrointestinal Cancers Symposium 2018 (January 18-20, 2018, San Francisco, CA), poster session
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1313
A phase Ib/II randomized study of mfolfirinox (mffox) + pegylated recombinant human hyaluronidase (pegph20) versus mffox alone in patients with good performance status metastatic pancreatic adenocarcinoma (mPC): SWOG S1313 (NCT #01959139)
- Journal / Conference
- JAMA Jul 10;320(2):167-176
- Year
- 2018
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- PMID29998338
- PMC
- PMC6583520
- Study Number(s)
- S1200
Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial
- Journal / Conference
- Journal of Clinical Oncology May 20;36(15):1498-1504; Apr 6 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Genitourinary
- PMID
- PMID29624463
- PMC
- PMC5959197
- Study Number(s)
- S9921
A Phase III IntergroupTrial of Adjuvant Androgen Deprivation +/- Mitoxantrone + Prednisone in Patients with High-Risk Prostate Cancer Post-Radical Prostatectomy: SWOG S9921
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl 6S; abstr TPS527); ASCO Genitourinary Cancers Symposium 2018 (Feb 8-10, 2018, San Francisco, CA)
- Year
- 2018
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1605
Phase II Trial of Atezolizumab in BCG-unresponsive Non-muscle Invasive Bladder Cancer
- Journal / Conference
- European Society for Radiotherapy & Oncology (ESTRO) (April 20-24, Barcelona, Spain), oral
- Year
- 2018
- Research Committee(s)
- Lung